Pages with the most revisions
Jump to navigation
Jump to search
Showing below up to 500 results in range #251 to #750.
View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)
- Time factor (2 revisions)
- Myocardial perfusion (2 revisions)
- Activity (2 revisions)
- What is Radon? (2 revisions)
- Oversight (2 revisions)
- Beta-minus decay (2 revisions)
- Projected dose (2 revisions)
- Clearance level (2 revisions)
- Radionuclides of natural origin (2 revisions)
- Recovery (cellular or tissue) (2 revisions)
- Retrievability (2 revisions)
- Immune system (2 revisions)
- Dose constraint (2 revisions)
- Institutional control (2 revisions)
- Early normal tissue responses (2 revisions)
- Stakeholder (2 revisions)
- Tachycardia (2 revisions)
- Tissue equivalent material (2 revisions)
- Myocardial stress test (2 revisions)
- Beta-plus decay (2 revisions)
- Calculating Doses from Intakes of Radionuclides (2 revisions)
- Radiation safety officer (2 revisions)
- Radioresponsiveness (2 revisions)
- Recovery responder (2 revisions)
- Cumulative dose (2 revisions)
- Reversibility (2 revisions)
- In vivo radiobioassay (2 revisions)
- Dose conversion coefficient (2 revisions)
- Solar particle event (2 revisions)
- Edema (2 revisions)
- Excess relative risk (2 revisions)
- Exposure situation (2 revisions)
- Worker (2 revisions)
- Nuclear track detectors (2 revisions)
- Growth factor (2 revisions)
- Alimentary tract transfer factor (2 revisions)
- Particle radiance (2 revisions)
- Hormones (2 revisions)
- Authorization (2 revisions)
- Protection strategy (2 revisions)
- Radiation source (2 revisions)
- Clonogenic cells (2 revisions)
- Radiosensitiser (2 revisions)
- Curie (2 revisions)
- Rehabilitation of living conditions (2 revisions)
- Right to know (2 revisions)
- Incidence (2 revisions)
- Solar wind (2 revisions)
- Effect Dose 50 (2 revisions)
- Endogeneous excretion (2 revisions)
- Target tissue (2 revisions)
- Measuring and Reducing Radon Levels in your Home (2 revisions)
- Exposure to Radon at Home (2 revisions)
- GATA binding protein 2 (2 revisions)
- Working level (2 revisions)
- OLINDA/EXM (2 revisions)
- Hounsfield unit (2 revisions)
- Authorized limit (2 revisions)
- Cardiac arrhythmias (2 revisions)
- Clonogenic survival (2 revisions)
- Radiosensitivity, cellular (2 revisions)
- Cytokines (2 revisions)
- Rigidity (2 revisions)
- Security (2 revisions)
- Incident (2 revisions)
- Intermediate level waste (2 revisions)
- Stenosis (2 revisions)
- Local DRL (2 revisions)
- Tolerability (2 revisions)
- Medical exposure (2 revisions)
- Naturally occurring radioactive material (2 revisions)
- Acute radiation syndrome (2 revisions)
- Working level month (2 revisions)
- Alveolar-interstitial region (2 revisions)
- Patient entrance reference point (2 revisions)
- Autoimmune disease (2 revisions)
- Potential recoverability correction factor (2 revisions)
- Protective action guide (2 revisions)
- ICRP Publication 118 (2 revisions)
- Cardiac valve diseases (2 revisions)
- Radiation worker (2 revisions)
- Disposal (2 revisions)
- Inclusiveness (2 revisions)
- Dose criteria (2 revisions)
- Source-related (2 revisions)
- Internal conversion electron (2 revisions)
- LD 50/30 (2 revisions)
- Environmental exposure (2 revisions)
- Telangiectasia (2 revisions)
- Exempt waste (2 revisions)
- Member of the public (2 revisions)
- Unattached fraction (2 revisions)
- Necrosis (2 revisions)
- Adaptive response (2 revisions)
- Peak skin dose (2 revisions)
- Radioactive dispersion device (2 revisions)
- Co-expertise (2 revisions)
- Radon: Units of Measure (2 revisions)
- Connective tissue (2 revisions)
- Reference air kerma (2 revisions)
- DRL process (2 revisions)
- Self-help protection (2 revisions)
- Individual-related (2 revisions)
- Storage (2 revisions)
- Environmental radiation protection (2 revisions)
- Exemption level (2 revisions)
- Track structure (2 revisions)
- Mendelian diseases (2 revisions)
- Neurological syndrome (2 revisions)
- Occupational exposure (2 revisions)
- Angiogenesis (2 revisions)
- Pelagic (2 revisions)
- Hyperbaric oxygen (2 revisions)
- Practical radiological protection culture (2 revisions)
- Bioturbation (2 revisions)
- Cardioverter-defibrillator (2 revisions)
- Radioactive source (2 revisions)
- Consequential late effects (2 revisions)
- ICRP Task Groups on Radiological Protection in Healthcare (2 revisions)
- Individual decontamination (2 revisions)
- Effective dose equivalent (2 revisions)
- Subcutaneous tissue (2 revisions)
- Low dose rate (2 revisions)
- Existing exposure situation (2 revisions)
- Transfer compartment (2 revisions)
- Mitigation (2 revisions)
- Upper reference levels (2 revisions)
- Neurovascular syndrome (2 revisions)
- Gastroschisis (2 revisions)
- Habitual mouth breather (2 revisions)
- Annihilation photons (2 revisions)
- Hyperfractionation (2 revisions)
- Bone marrow (2 revisions)
- Qualified expert (2 revisions)
- Radioactive substance (2 revisions)
- Cohort study (2 revisions)
- Reference biokinetic model (2 revisions)
- DRL value (2 revisions)
- Relocation (2 revisions)
- Risk coefficient (2 revisions)
- Individual monitoring (2 revisions)
- Source term (2 revisions)
- Latent time/period or latency interval (2 revisions)
- Epithelium (2 revisions)
- Low level waste (2 revisions)
- Acceptance test (2 revisions)
- Gastrulation (2 revisions)
- Habitual nose breather (2 revisions)
- Percutaneous coronary intervention (2 revisions)
- Hypertrophic cardiomyopathy (2 revisions)
- Background dose (rate) (2 revisions)
- Prevailing circumstances (2 revisions)
- Radon Recommendations for Authorities (2 revisions)
- Containment (2 revisions)
- Reference individual (2 revisions)
- Remedial action (2 revisions)
- ICRPædia Guide to Dose Coefficients (2 revisions)
- Dose-length product (2 revisions)
- Intervention Level (2 revisions)
- Substantial radiation dose level (2 revisions)
- Equieffective dose (2 revisions)
- Expanded and aligned radiation field (2 revisions)
- Transfer rate (2 revisions)
- Multi-detector computed tomography (2 revisions)
- Adventitious (2 revisions)
- Pericarditis (2 revisions)
- Hypoplasia (2 revisions)
- Backscatter detection system (2 revisions)
- Principle of application of dose limits (2 revisions)
- Bradycardia (2 revisions)
- Radioactivity (2 revisions)
- Radon Recommendations for Workplaces (2 revisions)
- Reference level (2 revisions)
- Remediation (2 revisions)
- Detriment (2 revisions)
- Risk of Exposure to Radon (2 revisions)
- Dose-rate effect (2 revisions)
- South Atlantic anomaly (2 revisions)
- Interventional procedure (2 revisions)
- Electron-capture decay (2 revisions)
- Lymphatic system (2 revisions)
- Transforming growth factor (2 revisions)
- Fluoroscopically or computed tomography guided interventions (2 revisions)
- Hazard (2 revisions)
- Bragg peak (2 revisions)
- Coronary heart disease (2 revisions)
- Decay constant (2 revisions)
- Repopulation (2 revisions)
- Routine monitoring (2 revisions)
- ICRPædia Guide to Radon (2 revisions)
- Dose of record Hp (10) (2 revisions)
- Special (non-routine) monitoring (2 revisions)
- Electrophysiology (2 revisions)
- Lifetime risk (2 revisions)
- Macrophage colony stimulating factor (2 revisions)
- Multiplicative risk projection model (2 revisions)
- Accreditation (2 revisions)
- Genomic integrity (2 revisions)
- Apoptosis (1 revision)
- Phantom (1 revision)
- ICRP Publication 11 (1 revision)
- ICRP Publication 124 (1 revision)
- ICRP Publication 139 (1 revision)
- Ras (1 revision)
- ICRP Publication 153 (1 revision)
- Reference phantom (1 revision)
- ICRP Publication 28 (1 revision)
- ICRP Publication 90 (1 revision)
- ICRP Publication 34 (1 revision)
- ICRP Publication 49 (1 revision)
- Size-specific dose estimate (1 revision)
- ICRP Publication 63 (1 revision)
- Specific absorbed fraction (1 revision)
- ICRP Publication 78 (1 revision)
- Elemental dose (1 revision)
- Surface contamination (1 revision)
- Exposed individuals (1 revision)
- 1954 Recommendations (1 revision)
- Translocation (1 revision)
- Multistage carcinogenesis model (1 revision)
- Organ at risk (1 revision)
- ICRP Publication 1 (1 revision)
- Baseline disease rates (1 revision)
- Principles of protection (1 revision)
- ICRP Publication 110 (1 revision)
- Breakpoint cluster region/abelson (1 revision)
- Radiation-induced second cancer (1 revision)
- ICRP Publication 125 (1 revision)
- ICRP Publication 14 (1 revision)
- Commissioning (1 revision)
- Rb (1 revision)
- ICRP Publication 154 (1 revision)
- Cosmic radiation (1 revision)
- Reference value (1 revision)
- ICRP Publication 29 (1 revision)
- ICRP Publication 91 (1 revision)
- ICRP Publication 35 (1 revision)
- ICRP Publication 5 (1 revision)
- Dose-threshold hypothesis (1 revision)
- Slice (1 revision)
- ICRP Publication 64 (1 revision)
- ICRP Publication 79 (1 revision)
- Threshold level (1 revision)
- 1956 Recommendations (1 revision)
- Activation (1 revision)
- Hereditary effect (1 revision)
- Pilomatricoma (1 revision)
- ICRP Publication 10 (1 revision)
- ICRP Publication 111 (1 revision)
- Radiation-induced secondary malignancy (1 revision)
- ICRP Publication 126 (1 revision)
- Radiological attack (1 revision)
- ICRP Publication 140 (1 revision)
- Reactive oxygen species (1 revision)
- ICRP Publication 155 (1 revision)
- Reference worker (1 revision)
- ICRP Publication 3 (1 revision)
- ICRP Publication 92 (1 revision)
- ICRP Publication 36 (1 revision)
- Dicentric chromosome (1 revision)
- ICRP Publication 50 (1 revision)
- Dose and dose-rate effectiveness factor (1 revision)
- Informed consent (1 revision)
- ICRP Publication 65 (1 revision)
- Spongiosa (1 revision)
- ICRP Publication 8 (1 revision)
- Marrow cellularity (1 revision)
- 1959 Decisions (1 revision)
- Multitarget equation (1 revision)
- ICRP Publication 100 (1 revision)
- ICRP Publication 112 (1 revision)
- ICRP Publication 127 (1 revision)
- Radiological controlled area (1 revision)
- ICRP Publication 141 (1 revision)
- ICRP Publication 16 (1 revision)
- Referrer (1 revision)
- ICRP Publication 30 (1 revision)
- Dental and maxillofacial imaging (1 revision)
- ICRP Publication 93 (1 revision)
- ICRP Publication 37 (1 revision)
- ICRU 4-element tissue (1 revision)
- ICRP Publication 51 (1 revision)
- ICRP Publication 66 (1 revision)
- ICRP Publication 80 (1 revision)
- System of radiological protection (1 revision)
- Time-resolved computed tomography (1 revision)
- Mutation component (1 revision)
- Active detection system (1 revision)
- Waste management (1 revision)
- Normal tissue complication probability (1 revision)
- Other (systemic) tissues (1 revision)
- Attributable risk (1 revision)
- ICRP Publication 101 (1 revision)
- Best available techniques (1 revision)
- ICRP Publication 113 (1 revision)
- Bronchiolar region (1 revision)
- ICRP Publication 128 (1 revision)
- ICRP Publication 142 (1 revision)
- Compartment (1 revision)
- ICRP Publication 17 (1 revision)
- Count median diameter (1 revision)
- Region (1 revision)
- ICRP Publication 30 (Index) (1 revision)
- ICRP Publication 94 (1 revision)
- ICRP Publication 38 (1 revision)
- ICRU sphere (1 revision)
- ICRP Publication 52 (1 revision)
- Dose commitment (1 revision)
- ICRP Publication 67 (1 revision)
- Doubling dose (1 revision)
- ICRP Publication 81 (1 revision)
- Evacuation (1 revision)
- Exposure index (1 revision)
- AML/eto (1 revision)
- Treatment preparation in radiotherapy (1 revision)
- Frequent flyer (1 revision)
- Notification value (1 revision)
- Pooled analysis (1 revision)
- ICRP Publication 101a (1 revision)
- ICRP Publication 114 (1 revision)
- Radiation risk (1 revision)
- ICRP Publication 129 (1 revision)
- ICRP Publication 143 (1 revision)
- Compartment (environmental) (1 revision)
- ICRP Publication 18 (1 revision)
- Cross section (1 revision)
- Regional diagnostic reference levels (1 revision)
- ICRP Publication 30 (Part 1) (1 revision)
- Deposition (1 revision)
- ICRP Publication 95 (1 revision)
- ICRP Publication 39 (1 revision)
- Digital breast tomosynthesis (1 revision)
- Sealed source (1 revision)
- ICRP Publication 53 (1 revision)
- Solar flare (1 revision)
- ICRP Publication 68 (1 revision)
- ICRP Publication 82 (1 revision)
- Linear dose response (1 revision)
- Excess absolute risk (1 revision)
- Mean glandular dose (1 revision)
- Exposure pathway (1 revision)
- Trophic level (1 revision)
- Functional subunits (1 revision)
- Activity median aerodynamic diameter (1 revision)
- Nuclear medicine (1 revision)
- Ground-level enhancement (1 revision)
- Oxygen enhancement ratio (1 revision)
- Homologous recombination (1 revision)
- Authorised discharge (1 revision)
- Population risk (1 revision)
- ICRP Publication 101b (1 revision)
- ICRP Publication 115 (1 revision)
- ICRP Publication 13 (1 revision)
- Clinical audit (1 revision)
- ICRP Publication 144 (1 revision)
- ICRP Publication 19 (1 revision)
- Registry (1 revision)
- ICRP Publication 30 (Part 2) (1 revision)
- ICRP Publication 96 (1 revision)
- ICRP Publication 4 (1 revision)
- Secondary radiation (1 revision)
- ICRP Publication 54 (1 revision)
- Intake (1 revision)
- ICRP Publication 69 (1 revision)
- Standard-size adult (1 revision)
- ICRP Publication 83 (1 revision)
- Tissue reaction (1 revision)
- Measured quantity (1 revision)
- Tumour suppressor gene (1 revision)
- National DRL (1 revision)
- Potential alpha energy concentration (1 revision)
- ICRP Publication 102 (1 revision)
- ICRP Publication 116 (1 revision)
- ICRP Publication 130 (1 revision)
- ICRP Publication 145 (1 revision)
- Redox (1 revision)
- ICRP Publication 2 (1 revision)
- ICRP Publication 30 (Part 3) (1 revision)
- Derived consideration reference level (1 revision)
- ICRP Publication 97 (1 revision)
- ICRP Publication 40 (1 revision)
- Secretory cells (1 revision)
- ICRP Publication 55 (1 revision)
- Dose conversion convention (1 revision)
- Intensity-modulated radiotherapy (1 revision)
- ICRP Publication 7 (1 revision)
- Stem cell (1 revision)
- Kerma approximation (1 revision)
- ICRP Publication 84 (1 revision)
- Exclusion (1 revision)
- National radon survey (1 revision)
- Acute exposure (1 revision)
- Allometry (1 revision)
- Particle transport (1 revision)
- Biological half-life (1 revision)
- ICRP Publication 117 (1 revision)
- ICRP Publication 131 (1 revision)
- ICRP Publication 146 (1 revision)
- Concentration ratio (1 revision)
- ICRP Publication 20 (1 revision)
- Relative biological effectiveness (1 revision)
- ICRP Publication 30 (Part 4) (1 revision)
- Derived investigation level (1 revision)
- ICRP Publication 98 (1 revision)
- ICRP Publication 41 (1 revision)
- Directional dose equivalent (1 revision)
- ICRP Publication 56 (1 revision)
- Dose conversion factor (1 revision)
- Somatic effect (1 revision)
- ICRP Publication 70 (1 revision)
- Effect modifier (1 revision)
- ICRP Publication 85 (1 revision)
- Endosteum (1 revision)
- Targeted effects (1 revision)
- Typical value (1 revision)
- Human Alimentary Tract Model (1 revision)
- ICRP Publication 104 (1 revision)
- Biomarker (1 revision)
- ICRP Publication 132 (1 revision)
- Clonogenic surviving fraction (1 revision)
- Radon-prone area (1 revision)
- ICRP Publication 147 (1 revision)
- Cone beam computed tomography (1 revision)
- Reference Person (1 revision)
- ICRP Publication 21 (1 revision)
- Relative life lost (1 revision)
- ICRP Publication 30 (Supplement A to Part 3) (1 revision)
- Derived limit (1 revision)
- ICRP Publication 99 (1 revision)
- ICRP Publication 42 (1 revision)
- Security screening (1 revision)
- ICRP Publication 57 (1 revision)
- ICRP Publication 71 (1 revision)
- Stochastic effect (1 revision)
- ICRP Publication 86 (1 revision)
- Tolerance dose (1 revision)
- Occupancy factor (1 revision)
- Ambient dose equivalent (1 revision)
- Human Respiratory Tract Model (1 revision)
- Automatic exposure control (1 revision)
- Potentially lethal damage repair (1 revision)
- ICRP Publication 105 (1 revision)
- ICRP Publication 119 (1 revision)
- ICRP Publication 133 (1 revision)
- ICRP Publication 148 (1 revision)
- ICRP Publication 22 (1 revision)
- Relative risk (1 revision)
- ICRP Publication 30 (Supplement B to Part 3) (1 revision)
- Derived reference level (1 revision)
- Ring chromosome (1 revision)
- ICRP Supporting Guidance 2 (1 revision)
- ICRP Publication 43 (1 revision)
- Disposal facility (1 revision)
- ICRP Publication 58 (1 revision)
- International Commission on Radiological Protection (1 revision)
- ICRP Publication 72 (1 revision)
- Lag (1 revision)
- ICRP Publication 87 (1 revision)
- Teratocarcinoma (1 revision)
- Low dose (1 revision)
- Absorption Type (1 revision - redirect page)
- Additional dose (1 revision)
- ICRP Publication 106 (1 revision)
- ICRP Publication 12 (1 revision)
- ICRP Publication 134 (1 revision)
- Cobblestone area forming cell assay (1 revision)
- ICRP Publication 149 (1 revision)
- ICRP Publication 23 (1 revision)
- DRL quantity (1 revision)
- Relative survival (1 revision)
- ICRP Publication 30 (Supplement to Part 1) (1 revision)
- Designated area (1 revision)
- ICRP Publication 44 (1 revision)
- Distribution coefficient (1 revision)
- ICRP Publication 59 (1 revision)
- Source region (1 revision)
- ICRP Publication 73 (1 revision)
- Late normal tissue responses (1 revision)
- ICRP Publication 88 (1 revision)
- Epigenetic effects (1 revision)
- 1928 Recommendations (1 revision)
- Additive risk projection model (1 revision)
- Α/β value (1 revision)
- Oncogene (1 revision)
- Pencil beam (1 revision)
- Practice (1 revision)
- ICRP Publication 107 (1 revision)
- ICRP Publication 120 (1 revision)
- Carers and comforters (1 revision)
- ICRP Publication 135 (1 revision)
- ICRP Publication 15 (1 revision)
- ICRP Publication 24 (1 revision)
- ICRP Publication 30 (Supplement to Part 2) (1 revision)
- Detector quantum efficiency (1 revision)
- ICRP Publication 45 (1 revision)
- Severe deterministic injury (1 revision)
- ICRP Publication 6 (1 revision)
- Intervention (1 revision)
- ICRP Publication 74 (1 revision)
- Sublethal damage repair (1 revision)
